Published in Immunotherapy Weekly, June 28th, 2006
According to a scientists in the United States, "Safe induction of autoantigen-specific long-term tolerance is the 'holy grail' for the treatment of autoimmune diseases. In animal models of type 1 diabetes, oral or i.n. immunization with islet antigens induces Tregs that are capable of bystander suppression. However, such interventions are only effective early in the prediabetic phase. We demonstrate that a novel combination treatment with anti-CD36-specific antibody and i.n. pro-insulin peptide can reverse recent-onset diabetes in two murine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.